toxoidum diphtheriae 20 U.I., toxoidum tetani 40 U.I., bordetellae pertussis antigenum: toxoidum pertussis 25 µg et haemagglutininum filamentosum 25 µg, virus poliomyelitis typus 1 inactivatus 29 U., virus poliomyelitis typus 2 inactivatus 7 U., virus poliomyelitis typus 3 inactivatus 26 U., aluminium 0.3 mg ut aluminii hydroxidum hydricum ad adsorptionem, formaldehydum, medium 199 cum phenylalaninum 12.5 µg et kalium, ethanolum 2 mg, phenoxyethanolum, acidum aceticum glaciale q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: glutaralum, neomycinum, streptomycinum, polymyxinum B.
Packungsbestandteile
Injection suspension
Active Agent
Dose
Toxoidum Diphtheriae
20 UI
Toxoidum Tetani
40 UI
BAG: Active Agent
Dose
Toxoidum Diphtheriae
20 UI
Toxoidum Pertussis
25 mcg
Toxoidum Tetani
40 UI
Vaccinum Poliomyelitidis Inactivatum (Salk typ I, II, III)
62 U
Inactive agents
Dose
additional_information
Acidum Aceticum Glaciale
Alumine
0.3 mg
Cum Phenylalaninum
12.5 µg
Ethanol
2 mg
Formaldehydum
Haemagglutininum Filamentosum
25 µg
Inactivatus
26 U
Potassium
Medium
199
Phenoxyethanol
Toxoidum Pertussis
25 µg
bordetellae pertussis antigenum
Virus Poliomyelitis Typus
3
Source
Data was imported : 04.04.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
